List of Tables
Table 1. Glanzmann Thrombasthenia Therapeutic Drug Market Trends
Table 2. Glanzmann Thrombasthenia Therapeutic Drug Market Drivers & Opportunity
Table 3. Glanzmann Thrombasthenia Therapeutic Drug Market Challenges
Table 4. Glanzmann Thrombasthenia Therapeutic Drug Market Restraints
Table 5. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Glanzmann Thrombasthenia Therapeutic Drug Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Glanzmann Thrombasthenia Therapeutic Drug Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Glanzmann Thrombasthenia Therapeutic Drug Product Type
Table 9. Key Companies Time to Begin Mass Production of Glanzmann Thrombasthenia Therapeutic Drug
Table 10. Global Glanzmann Thrombasthenia Therapeutic Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glanzmann Thrombasthenia Therapeutic Drug as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Glanzmann Thrombasthenia Therapeutic Drug Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Glanzmann Thrombasthenia Therapeutic Drug Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Glanzmann Thrombasthenia Therapeutic Drug Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Glanzmann Thrombasthenia Therapeutic Drug Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Region (2019-2024) & (%)
Table 27. Global Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Glanzmann Thrombasthenia Therapeutic Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Glanzmann Thrombasthenia Therapeutic Drug Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Glanzmann Thrombasthenia Therapeutic Drug Sales Value, (2025-2030) & (US$ Million)
Table 31. Novo Nordisk Basic Information List
Table 32. Novo Nordisk Description and Business Overview
Table 33. Novo Nordisk Glanzmann Thrombasthenia Therapeutic Drug Products, Services and Solutions
Table 34. Revenue (US$ Million) in Glanzmann Thrombasthenia Therapeutic Drug Business of Novo Nordisk (2019-2024)
Table 35. Novo Nordisk Recent Developments
Table 36. Alnylam Pharmaceuticals Basic Information List
Table 37. Alnylam Pharmaceuticals Description and Business Overview
Table 38. Alnylam Pharmaceuticals Glanzmann Thrombasthenia Therapeutic Drug Products, Services and Solutions
Table 39. Revenue (US$ Million) in Glanzmann Thrombasthenia Therapeutic Drug Business of Alnylam Pharmaceuticals (2019-2024)
Table 40. Alnylam Pharmaceuticals Recent Developments
Table 41. Shire (Takeda) Basic Information List
Table 42. Shire (Takeda) Description and Business Overview
Table 43. Shire (Takeda) Glanzmann Thrombasthenia Therapeutic Drug Products, Services and Solutions
Table 44. Revenue (US$ Million) in Glanzmann Thrombasthenia Therapeutic Drug Business of Shire (Takeda) (2019-2024)
Table 45. Shire (Takeda) Recent Developments
Table 46. Biogen Basic Information List
Table 47. Biogen Description and Business Overview
Table 48. Biogen Glanzmann Thrombasthenia Therapeutic Drug Products, Services and Solutions
Table 49. Revenue (US$ Million) in Glanzmann Thrombasthenia Therapeutic Drug Business of Biogen (2019-2024)
Table 50. Biogen Recent Developments
Table 51. Bioverativ (Sanofi) Basic Information List
Table 52. Bioverativ (Sanofi) Description and Business Overview
Table 53. Bioverativ (Sanofi) Glanzmann Thrombasthenia Therapeutic Drug Products, Services and Solutions
Table 54. Revenue (US$ Million) in Glanzmann Thrombasthenia Therapeutic Drug Business of Bioverativ (Sanofi) (2019-2024)
Table 55. Bioverativ (Sanofi) Recent Developments
Table 56. Bayer Basic Information List
Table 57. Bayer Description and Business Overview
Table 58. Bayer Glanzmann Thrombasthenia Therapeutic Drug Products, Services and Solutions
Table 59. Revenue (US$ Million) in Glanzmann Thrombasthenia Therapeutic Drug Business of Bayer (2019-2024)
Table 60. Bayer Recent Developments
Table 61. CSL Behring Basic Information List
Table 62. CSL Behring Description and Business Overview
Table 63. CSL Behring Glanzmann Thrombasthenia Therapeutic Drug Products, Services and Solutions
Table 64. Revenue (US$ Million) in Glanzmann Thrombasthenia Therapeutic Drug Business of CSL Behring (2019-2024)
Table 65. CSL Behring Recent Developments
Table 66. Grifols Basic Information List
Table 67. Grifols Description and Business Overview
Table 68. Grifols Glanzmann Thrombasthenia Therapeutic Drug Products, Services and Solutions
Table 69. Revenue (US$ Million) in Glanzmann Thrombasthenia Therapeutic Drug Business of Grifols (2019-2024)
Table 70. Grifols Recent Developments
Table 71. Bristol-Myers Squibb Basic Information List
Table 72. Bristol-Myers Squibb Description and Business Overview
Table 73. Bristol-Myers Squibb Glanzmann Thrombasthenia Therapeutic Drug Products, Services and Solutions
Table 74. Revenue (US$ Million) in Glanzmann Thrombasthenia Therapeutic Drug Business of Bristol-Myers Squibb (2019-2024)
Table 75. Bristol-Myers Squibb Recent Developments
Table 76. Pfizer Basic Information List
Table 77. Pfizer Description and Business Overview
Table 78. Pfizer Glanzmann Thrombasthenia Therapeutic Drug Products, Services and Solutions
Table 79. Revenue (US$ Million) in Glanzmann Thrombasthenia Therapeutic Drug Business of Pfizer (2019-2024)
Table 80. Pfizer Recent Developments
Table 81. Key Raw Materials Lists
Table 82. Raw Materials Key Suppliers Lists
Table 83. Glanzmann Thrombasthenia Therapeutic Drug Downstream Customers
Table 84. Glanzmann Thrombasthenia Therapeutic Drug Distributors List
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Glanzmann Thrombasthenia Therapeutic Drug Product Picture
Figure 2. Global Glanzmann Thrombasthenia Therapeutic Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Glanzmann Thrombasthenia Therapeutic Drug Sales Value (2019-2030) & (US$ Million)
Figure 4. Glanzmann Thrombasthenia Therapeutic Drug Report Years Considered
Figure 5. Global Glanzmann Thrombasthenia Therapeutic Drug Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Glanzmann Thrombasthenia Therapeutic Drug Revenue in 2023
Figure 7. Glanzmann Thrombasthenia Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Platelet Transfusion Picture
Figure 9. Recombinant Activated Factor VII Picture
Figure 10. Antifibrinolytics Picture
Figure 11. Fibrin Sealants Picture
Figure 12. Thrombin Picture
Figure 13. Desmopressin Picture
Figure 14. Global Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Glanzmann Thrombasthenia Therapeutic Drug Sales Value Market Share by Type, 2023 & 2030
Figure 16. Product Picture of Hospital
Figure 17. Product Picture of Clinic
Figure 18. Product Picture of Others
Figure 19. Global Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Glanzmann Thrombasthenia Therapeutic Drug Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Glanzmann Thrombasthenia Therapeutic Drug Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Glanzmann Thrombasthenia Therapeutic Drug Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Glanzmann Thrombasthenia Therapeutic Drug Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Glanzmann Thrombasthenia Therapeutic Drug Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Glanzmann Thrombasthenia Therapeutic Drug Sales Value (%), (2019-2030)
Figure 32. United States Glanzmann Thrombasthenia Therapeutic Drug Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Glanzmann Thrombasthenia Therapeutic Drug Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Application (%), 2023 VS 2030
Figure 38. China Glanzmann Thrombasthenia Therapeutic Drug Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Type (%), 2023 VS 2030
Figure 40. China Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Glanzmann Thrombasthenia Therapeutic Drug Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Glanzmann Thrombasthenia Therapeutic Drug Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Glanzmann Thrombasthenia Therapeutic Drug Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Application (%), 2023 VS 2030
Figure 50. India Glanzmann Thrombasthenia Therapeutic Drug Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Type (%), 2023 VS 2030
Figure 52. India Glanzmann Thrombasthenia Therapeutic Drug Sales Value by Application (%), 2023 VS 2030
Figure 53. Glanzmann Thrombasthenia Therapeutic Drug Industrial Chain
Figure 54. Glanzmann Thrombasthenia Therapeutic Drug Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
